For all these reasons, we aimed to investigate whether various oxidant and antioxidant variables, including MDA, NO, GSH-Px, CAT, and SOD levels, can be used as reliable biomarkers for multiple myeloma and to assess which variables might be more sensitive in predicting multiple myeloma. The gene discussed is SOD1; the disease is plasma cell myeloma.